Literature DB >> 19319688

Physicochemical properties of solid dispersions of gliclazide in polyvinylpyrrolidone K90.

S Biswal1, J Sahoo, P N Murthy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19319688      PMCID： PMC2690775          DOI： 10.1208/s12249-009-9212-7

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN： 1530-9932            Impact factor:   3.246


× No keyword cloud information.
  22 in total

1.  Physicochemical characterization and in vivo properties of Zolpidem in solid dispersions with polyethylene glycol 4000 and 6000.

Authors:  G Trapani; M Franco; A Latrofa; M R Pantaleo; M R Provenzano; E Sanna; E Maciocco; G Liso
Journal:  Int J Pharm       Date:  1999-07-05       Impact factor: 5.875

2.  The concept of dissolution efficiency.

Authors:  K A Khan
Journal:  J Pharm Pharmacol       Date:  1975-01       Impact factor: 3.765

3.  Dissolution properties and in vivo behaviour of triamterene in solid dispersions with polyethylene glycols.

Authors:  M J Arias; J M Ginés; J R Moyano; A M Rabasco
Journal:  Pharm Acta Helv       Date:  1996-10

Review 4.  The current status of solid dispersions.

Authors:  J L Ford
Journal:  Pharm Acta Helv       Date:  1986

5.  Properties of solid dispersions of piroxicam in polyvinylpyrrolidone.

Authors:  V Tantishaiyakul; N Kaewnopparat; S Ingkatawornwong
Journal:  Int J Pharm       Date:  1999-04-30       Impact factor: 5.875

6.  Miscibility behavior and formation mechanism of stabilized felodipine-polyvinylpyrrolidone amorphous solid dispersions.

Authors:  Evangelos Karavas; Georgios Ktistis; Aristotelis Xenakis; Emmanouel Georgarakis
Journal:  Drug Dev Ind Pharm       Date:  2005-07       Impact factor: 3.225

7.  Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrj 52, lactose, sorbitol, dextrin, and Eudragit E100.

Authors:  Hadi Valizadeh; Ali Nokhodchi; Nahid Qarakhani; Parvin Zakeri-Milani; Shirzad Azarmi; Davood Hassanzadeh; Raimar Löbenberg
Journal:  Drug Dev Ind Pharm       Date:  2004-03       Impact factor: 3.225

Review 8.  Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus.

Authors:  K J Palmer; R N Brogden
Journal:  Drugs       Date:  1993-07       Impact factor: 9.546

9.  Accelerated oral absorption of gliclazide in human subjects from a soft gelatin capsule containing a PEG 400 suspension of gliclazide.

Authors:  S S Hong; S H Lee; Y J Lee; S J Chung; M H Lee; C K Shim
Journal:  J Control Release       Date:  1998-02-12       Impact factor: 9.776

Review 10.  Comparison of efficacy, secondary failure rate, and complications of sulfonylureas.

Authors:  A D Harrower
Journal:  J Diabetes Complications       Date:  1994 Oct-Dec       Impact factor: 2.852
View more
  9 in total

1.  Formulation and Pharmacokinetic Evaluation of Polymeric Dispersions Containing Valsartan.

Authors:  Naveen Chella; Bhaskar Daravath; Dinesh Kumar; Rama Rao Tadikonda
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-10       Impact factor: 2.441

2.  Three-Dimensional (3D)-Printed Zero-Order Released Platform: a Novel Method of Personalized Dosage Form Design and Manufacturing.

Authors:  Dongyang Fang; Yining Yang; Mengsuo Cui; Hao Pan; Lijie Wang; Pingfei Li; Wenjing Wu; Sen Qiao; Weisan Pan
Journal:  AAPS PharmSciTech       Date:  2021-01-06       Impact factor: 3.246

3.  Physicochemical investigations and stability studies of amorphous gliclazide.

Authors:  Shital Jondhale; Satish Bhise; Yogesh Pore
Journal:  AAPS PharmSciTech       Date:  2012-03-02       Impact factor: 3.246

4.  Toxicity studies of nanofabricated palladium against filariasis and malaria vectors.

Authors:  Chidambaram Jayaseelan; Pachiyappan Rajiv Gandhi; Santha Ravindranath Radhika Rajasree; Thodhal Yoganandham Suman; Rathinasamy Regina Mary
Journal:  Environ Sci Pollut Res Int       Date:  2017-10-15       Impact factor: 4.223

5.  Controlled porosity solubility modulated osmotic pump tablets of gliclazide.

Authors:  Arti Banerjee; P R P Verma; Subhash Gore
Journal:  AAPS PharmSciTech       Date:  2014-11-07       Impact factor: 3.246

6.  Transport and Biotransformation of Gliclazide and the Effect of Deoxycholic Acid in a Probiotic Bacteria Model.

Authors:  Maja Ðanić; Bojan Stanimirov; Nebojša Pavlović; Saša Vukmirović; Jelena Lazić; Hani Al-Salami; Momir Mikov
Journal:  Front Pharmacol       Date:  2019-09-24       Impact factor: 5.810

7.  Lipid-Based Gliclazide Nanoparticles for Treatment of Diabetes: Formulation, Pharmacokinetics, Pharmacodynamics and Subacute Toxicity Study.

Authors:  Alaa Mohamed Nazief; Passainte Saber Hassaan; Hoda Mahmoud Khalifa; Magda Samir Sokar; Amal Hassan El-Kamel
Journal:  Int J Nanomedicine       Date:  2020-02-18

8.  Mutual Effects of Hydrogen Bonding and Polymer Hydrophobicity on Ibuprofen Crystal Inhibition in Solid Dispersions with Poly(N-vinyl pyrrolidone) and Poly(2-oxazolines).

Authors:  Xiaoning Shan; Maryam A Moghul; Adrian C Williams; Vitaliy V Khutoryanskiy
Journal:  Pharmaceutics       Date:  2021-05-04       Impact factor: 6.321

9.  Preparation of solid dispersion systems for enhanced dissolution of poorly water soluble diacerein: In-vitro evaluation, optimization and physiologically based pharmacokinetic modeling.

Authors:  Shahinaze A Fouad; Fady A Malaak; Mohamed A El-Nabarawi; Khalid Abu Zeid; Amira M Ghoneim
Journal:  PLoS One       Date:  2021-01-20       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.